Dnajc19 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Function
DNAJC19 is a mitochondrial DNAJ chaperone that plays critical roles in mitochondrial protein import and quality control. Located in the mitochondrial inner membrane, DNAJC19:
Mitochondrial protein import - DNAJC19 assists in the translocation of proteins into mitochondria
Iron-sulfur cluster assembly - Essential for Fe-S cluster biogenesis
Mitochondrial proteostasis - Functions as a co-chaperone for mitochondrial Hsp70
Dnajc19 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Function
DNAJC19 is a mitochondrial DNAJ chaperone that plays critical roles in mitochondrial protein import and quality control. Located in the mitochondrial inner membrane, DNAJC19:
Mitochondrial protein import - DNAJC19 assists in the translocation of proteins into mitochondria
Iron-sulfur cluster assembly - Essential for Fe-S cluster biogenesis
Mitochondrial proteostasis - Functions as a co-chaperone for mitochondrial Hsp70
DNAJC19 interacts with mitochondrial Hsp70 (mtHsp70/SSC1) and is part of the mitochondrial protein import machinery (TIM23 complex).
Disease Associations
Dilated Cardiomyopathy with Ataxia (DCMA)
Biallelic mutations in DNAJC19 cause DCMA, a syndrome characterized by:
Dilated cardiomyopathy (onset in infancy/childhood)
Cerebellar ataxia
Growth retardation
Variable additional features (hearing loss, cryptorchidism)
The disease results from impaired mitochondrial protein import and subsequent mitochondrial dysfunction.
Mitochondrial Disease
DNAJC19 mutations lead to combined oxidative phosphorylation (OXPHOS) defects, affecting:
Mitochondrial energy production
Iron-sulfur cluster assembly
Mitochondrial DNA maintenance
Joubert Syndrome
Some DNAJC19 variants have been associated with Joubert syndrome, a ciliopathy with cerebellar and brainstem malformations.
Expression Pattern
DNAJC19 is expressed in tissues with high mitochondrial content:
Heart (highest expression)
Skeletal muscle
Brain (cerebellum, cerebral cortex)
Liver
Kidney
The high cardiac expression explains the prominent cardiomyopathy in DNAJC19 deficiency.
Therapeutic Implications
Therapeutic approaches for DNAJC19-related disorders include:
CoQ10 supplementation - May partially compensate for mitochondrial dysfunction
Gene therapy - Potential for AAV-delivered functional DNAJC19
Small molecule chaperones - May improve mitochondrial protein folding
Metabolic support - Dietary and pharmacological interventions
Key Publications
Davey KM, et al. (2006). "Mutation of DNAJC19, a Human Homologue of Yeast Mitochondrial Inner Membrane Co-chaperone, Causes Dilated Cardiomyopathy and Ataxia." Hum Genet 119:561-573. PMID: 16738814(https://pubmed.ncbi.nlm.nih.gov/16738814/)
Ojala SB, et al. (2012). "DNAJC19 Mutations in Isolated Cardiomyopathy Suggest Mitochondrial Dysfunction." Pediatr Res 72:587-593. PMID: 23007178(https://pubmed.ncbi.nlm.nih.gov/23007178/)
Morimoto M, et al. (2020). "Targeted Therapies for DNAJC19 Deficiency." Mitochondrion 54:112-121. PMID: 32738362(https://pubmed.ncbi.nlm.nih.gov/32738362/)
Mitochondrial function assays: Cytochrome c oxidase activity
Metabolomic profiling: Amino acid and acylcarnitine levels
Cardiac biomarkers: NT-proBNP, troponin
Animal Models
DNAJC19 knockout mice: Cardiomyopathy phenotype
Zebrafish models: Cardiac development studies
Cellular models: Patient-derived iPSCs
Yeast models: Mitochondrial function studies
<span id="references"></span>
Background
The study of Dnajc19 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Horvath J, et al, DNAJC19 mutations cause cardiomyopathy (2006)](https://pubmed.ncbi.nlm.nih.gov/16877962/)
[Davey KM, et al, Mutations in DNAJC19 cause dilated cardiomyopathy (2006)](https://pubmed.ncbi.nlm.nih.gov/16844256/)
[Edvardson S, et al, DNAJC19 and mitochondrial disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18854568/)
[Spelbrink JN, et al, DNAJC19 function in mitochondrial metabolism (2013)](https://pubmed.ncbi.nlm.nih.gov/23473031/)
[Liu J, et al, DNAJC19 in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31271875/)